Aniwaa Owusu Obeng

Dr. Aniwaa Owusu Obeng


Research Focus & Metrics

Academic Career Length

11Years (2016-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
6 September 2017 in Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy
Verified
Journal Article
Closed access
PDF file
AOAniwaa Owusu Obeng
Aniwaa Owusu Obeng
IHIssam Hamadeh
Issam Hamadeh
MSMichael Smith
Michael Smith

Verified
Journal Article
Open access
PDF file
AOAniwaa Owusu Obeng
Aniwaa Owusu Obeng
KFKezhen Fei
Kezhen Fei
KLKenneth D. Levy
Kenneth D. Levy
AEAmanda R. Elsey
Amanda R. Elsey
TPToni I Pollin
Toni I Pollin
CHCarol R. Horowitz
Carol R. Horowitz
Genetic medicine is one of the key components of personalized medicine, but adoption in clinical practice is still limited. To understand potential barriers and provider attitudes, we surveyed 285 physicians from five Implementing GeNomics In pracTicE (IGNITE) sites about their perceptions as to the clinical utility of genetic data as well as their preparedness to integrate it into practice. These responses were also analyzed in comparison to the type of study occurring at the physicians’ institution (pharmacogenetics versus disease genetics). The majority believed that genetic testing is clinically useful; however, only a third believed that they had obtained adequate training to care for genetically “high-risk” patients. Physicians involved in pharmacogenetics initiatives were more favorable towards genetic testing applications; they found it to be clinically useful and felt more prepared and confident in their abilities to adopt it into their practice in comparison to those participating in disease genetics initiatives. These results suggest that investigators should explore which attributes of clinical pharmacogenetics (such as the use of simplified genetics-guided recommendations) can be implemented to improve attitudes and preparedness to implement disease genetics in care. Most physicians felt unprepared to use genetic information in their practice; accordingly, major steps should be taken to develop effective clinical tools and training strategies for physicians.

17 May 2019 in American Journal of Health-System Pharmacy
Verified
Journal Article
Closed access
PDF file
SCShanice Coriolan
Shanice Coriolan
NANimota Arikawe
Nimota Arikawe
AMArden Moscati
Arden Moscati
LZLisheng Zhou
Lisheng Zhou
SDStephanie Dym
Stephanie Dym
AOAniwaa Owusu Obeng
Aniwaa Owusu Obeng
Purpose: To evaluate final-year pharmacy students’ perceptions toward pharmacogenomics education, their attitudes on its clinical relevance, and their readiness to use such knowledge in practice.Methods: A 19-question survey was developed and modified from prior studies and was pretested on a small group of pharmacogenomics faculty and pharmacy students. The final survey was administered to 978 final-year pharmacy students in 8 school/colleges of pharmacy in New York and New Jersey between January and May 2017. The survey targeted 3 main themes: perceptions toward pharmacogenomics education, attitudes toward the clinical relevance of this education, and the students’ readiness to use knowledge of pharmacogenomics in practice.Results: With a 35% response rate, the majority (81%) of the 339 student participants believed that pharmacogenomics was a useful clinical tool for pharmacists, yet only 40% felt that it had been a relevant part of their training. Almost half (46%) received only 1–3 lectures on pharmacogenomics and the majority were not ready to use it in practice. Survey results pointed toward practice-based trainings such as pharmacogenomics rotations as the most helpful in preparing students for practice.Conclusions: Final-year student pharmacists reported varying exposure to pharmacogenomics content in their pharmacy training and had positive attitudes toward the clinical relevance of the discipline, yet they expressed low confidence in their readiness to use this information in practice.

9 July 2016 in Clinical Pharmacology & Therapeutics
Verified
Journal Article
Closed access
PDF file
AOAniwaa Owusu Obeng
Aniwaa Owusu Obeng
TKT Kaszemacher
T Kaszemacher
Noura Abul-HusnNoura Abul-Husn
Noura Abul-Husn
OGO Gottesman
O Gottesman
AVA Vega
A Vega
SSSa Scott
Sa Scott

1 January 2017 in Interventional Cardiology Clinics
Verified
Journal Article
Closed access
LCLarisa H. Cavallari
Larisa H. Cavallari
AOAniwaa Owusu Obeng
Aniwaa Owusu Obeng

17 November 2022 in Clinical Pharmacology & Therapeutics
Verified
Journal Article
Closed access
AOAniwaa Owusu Obeng
Aniwaa Owusu Obeng
Stuart ScottStuart Scott
Stuart Scott
TKTom Kaszemacher
Tom Kaszemacher
SEStephen B. Ellis
Stephen B. Ellis
AMAna Mejia
Ana Mejia
EBErwin P. Bottinger
Erwin P. Bottinger